The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of genetic mutation profile and CNS pharmacokinetics in relapsed/refractory primary CNS lymphoma patients responding to novel emavusertib (IRAK4i) and BTKi combination.
 
Christian Grommes
Honoraria - Scripps Health
Consulting or Advisory Role - BTG; Curis; Kite/Gilead; Ono Pharmaceutical; Roche
Speakers' Bureau - Ono Pharmaceutical
Travel, Accommodations, Expenses - Ono Pharmaceutical
Other Relationship - Bayer; Bristol-Myers Squibb; Celgene; Pharmacyclics
 
Anna Dabrowska-Iwanicka
Honoraria - Curis
Consulting or Advisory Role - Curis
 
Han Tun
Consulting or Advisory Role - Curis
 
Christopher D'Angelo
Consulting or Advisory Role - Curis
 
Adolfo De La Fuente
Consulting or Advisory Role - Curis
 
Itai Levi
Consulting or Advisory Role - Curis
 
Lakshmi Nayak
Honoraria - Ono Pharmaceutical
Consulting or Advisory Role - BraveBio; Genmab; Kite/Gilead; Ono Pharmaceutical
Speakers' Bureau - Ono Pharmaceutical
Research Funding - AstraZeneca (Inst); Kazia Therapeutics (Inst); Merck (Inst); Ono Pharmaceutical (Inst)
Patents, Royalties, Other Intellectual Property - Wolters Kluwer/ UpToDate, Inc- Royalty
Travel, Accommodations, Expenses - Ono Pharmaceutical
 
David Lavie
Consulting or Advisory Role - Abbvie; GlaxoSmithKline; Novartis; Roche; Takeda
Travel, Accommodations, Expenses - Abbvie; NeoPharm
 
Alessia Castellino
No Relationships to Disclose
 
Michal Taszner
No Relationships to Disclose
 
Praveen Ramakrishnan
Consulting or Advisory Role - ADC Therapeutics; BMS; Cellectar; Ipsen; Kite/ Gilead Pharma; Ono Pharmaceutical; Regeneron
 
Laurence Schenone
No Relationships to Disclose
 
Andrés Ferreri
Consulting or Advisory Role - Abbvie; AstraZeneca; BMSi; Genmab; Incyte; Kite/Gilead; Novartis Italy; PletixaPharm; Roche
Speakers' Bureau - Roche Italy
Research Funding - ADC Therapeutics (Inst); Amgen (Inst); BeiGene (Inst); BMS (Inst); Celgene (Inst); Genmab (Inst); Gilead Sciences (Inst); Hutchison MediPharma (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - NGR-hTNF/RCHOP in relapsed or refractory PCNSL (Inst); SNGR-hTNF in brain tumours (Inst)
Travel, Accommodations, Expenses - BeiGene; Janssen
 
Teresa Calimeri
No Relationships to Disclose
 
Luca Nassi
Employment - Sanofi (I)
Consulting or Advisory Role - Kyowa Kirin International; Roche; Takeda
Patents, Royalties, Other Intellectual Property - MolMed; Sanofi (I)
 
Caroline Houillier
No Relationships to Disclose
 
Anna Schmitt
Travel, Accommodations, Expenses - Janssen; sanofi
 
Gaurav Choudhary
Employment - Curis
Stock and Other Ownership Interests - Curis
Patents, Royalties, Other Intellectual Property - Curis
Travel, Accommodations, Expenses - Curis
 
Wanying Zhao
Employment - Curis
Stock and Other Ownership Interests - Curis
Patents, Royalties, Other Intellectual Property - Curis
 
Grzegorz Nowakowski
Consulting or Advisory Role - Abbvie; Bantam Pharmaceutical; Bristol-Myers Squibb/Celgene; Celgene (Inst); Debiopharm Group; Genentech (Inst); Genmab; Karyopharm Therapeutics; Kite/Gilead; kymera; MorphoSys (Inst); Roche Pharma AG (Inst); Ryvu Therapeutics; Selvita; TG Therapeutics
Research Funding - Celgene (Inst); MorphoSys (Inst); NanoString Technologies (Inst)